VISACards AcceptedFree Shipping Over $300GTA Third-Party TestedShips Canada-Wide3+ Vials — 10% Off5+ Vials — 20% Off10+ Vials — 40% OffVISACards AcceptedFree Shipping Over $300GTA Third-Party TestedShips Canada-Wide3+ Vials — 10% Off5+ Vials — 20% Off10+ Vials — 40% Off
Coming Soon

Cardiogen

20 mg (lyophilized)

Purity:

≥99% (HPLC)

Cardiogen 20 mg (lyophilized) research vial
Research peptide · RUO · Canada

Cardiogen

20 mg (lyophilized)

Formula
N/ACAD · per vial

+ $25 flat-rate shipping · free at $300+ · Interac e-Transfer · VISA

1
Inquire
Purity≥99% (HPLC)
Storage-20°C
FormLyophilized
TestingHPLC
🏦Interac e-Transfer
COA policy·Returns

About this compound

Cardiogen (Ala-Glu-Asp-Arg) is a tetrapeptide bioregulator originally identified from cardiac tissue extracts. It has been studied for its potential role in modulating gene expression in cardiomyocytes and supporting the structural and functional integrity of cardiac muscle cells. Preclinical and early clinical research — primarily conducted in Eastern European academic settings — has examined Cardiogen for its cytoprotective properties in the myocardium, particularly under conditions of oxidative stress, ischemia, and age-related cellular decline. As a short peptide bioregulator, it is proposed to exert regulatory effects at the chromatin level by interacting with gene promoter regions, influencing protein synthesis in cardiac tissue.

Storage and handling

Lyophilized storage

Store at -20°C lyophilized, away from moisture and UV light. Keep vials sealed until use. Stable for 2+ years in a non-frost-free freezer.

Preclinical research references

Provided for informational context only. All cited studies involve preclinical or in vitro models. Results do not predict human safety or efficacy. These references do not constitute medical claims.

  • In vitro studies using isolated cardiomyocyte cultures demonstrated that Cardiogen treatment attenuated oxidative stress markers and reduced apoptotic signaling under hypoxic conditions, suggesting potential cytoprotective activity in cardiac cells (Khavinson et al., 2003)
  • Aged rat models showed that Cardiogen administration was associated with partial normalization of cardiomyocyte ultrastructure and reduced lipofuscin accumulation in myocardial tissue compared to untreated aged controls (Malinin et al., 2006)
  • Peptide bioregulator studies indicated Cardiogen may influence expression of genes involved in cardiac cell proliferation and differentiation, with observed effects on chromatin conformation in cardiomyocyte nuclei in ex vivo preparations (Khavinson & Morozov, 2003)

Shipping & returns

Shipping

1–5 business days, Canada-wide tracked courier, double tamper-proof packaging.

Returns

All sales final. Damaged or incorrect orders must be reported within 24 hours with photos.

Quality assurance

Every batch independently tested for purity. COA on file and available before purchase.

FAQ — Cardiogen

For research use only. Not for human or veterinary administration.

Research updates

Stay ahead of new batches.

New compounds, COA releases, batch testing results, and research content — straight to your inbox.

Research Use Only (RUO): All products are strictly for laboratory research. Not for human or veterinary use. Full disclaimer →